InstituteOfScience.com
Copyright 1995-2001 S.H. Shakman, Institute Of Science; all
rights reserved.
SERUM THERAPY BENEFIT NOT DUE TO "PASSIVE" MECHANISM - 17A1
Spiethoff [17A1] per JAMA [68 (1917),316] contrasted the
equally favorable results obtained with autogenous serum with
those of alien serotherapy, pointing out that "The benefit does
not depend on supplying certain lacking elements but on a broader
principle which includes the individual's own serum."
VENESECTION IS VACCINETHERAPY 17A1
AUTOSERUM IS VACCINETHERAPY - 17A1
Spiethoff [17A1] per JAMA [68 (1917),408] offers that "The
benefit from venesection and the reinjection of serum is best
explained by stimulation of the production of antibodies and
their mobilization."
AUTOSEROTHERAPY, SAFETY OF - 17A1
Spiethoff [17A1] noted that he had "never witnessed with this
form of serotherapy [autogenous] anything like the phenomena of
hypersusceptibility sometimes noted with foreign serum, but there
is usually a transient general and a focal reaction."
AUTOSERUM, RESULTS OF - 17A1
AUTOSERUM FOR URTICARIA - 17A1
AUTOSERUM FOR ECZEMA - 17A1
AUTOSERUM FOR PEMPHIGUS - 17A1
AUTOSERUM FOR SCALP DISEASE - 17A1
AUTOSERUM FOR GANGRENOUS ULCERS - 17A1
AUTOSERUM FOR PRURITIS - 17A1
Spiethoff [17A1] relates promising experiences in cases of
urticaria, eczema, pemphigus, scalp disease, gangrenous ulcers,
and particular good results with pruritis.